Companies & Industry »Company News»Company News Details
Company News Details

BSE   30 May 16 | 12:00 AM

333.35 6 (1.83%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   30 May 16 | 12:00 AM

334.10 6.9 (2.11%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 324.90 (2.60%)
1 Month : Rs 327.00 (1.94%)
1 Year : Rs 376.15 (-11.38%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Tata Motors420.554.23
Coal India292.053.80
Hero Motocorp3,093.903.02
TCS2,635.352.46
NTPC143.102.29

Online Portfolio

You can create Online Portfolio here using the below button.